Brian S Posner Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian S Posner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian S Posner. Brian S Posner is Director in ARCH CAPITAL GROUP LTD. ($ACGL) and Director in BIOGEN INC. ($IDPH) and Officer of the Adviser in LMP CAPITAL & INCOME FUND INC. ($SCD) and Director in Bioverativ Inc. ($BIVV).
Latest Insider Trading Transactions of Brian S Posner
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACGL, IDPH, BIVV, SCD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 3,143 | 0 | 110,087 | 106.9 K to 110.1 K (+2.94 %) |
| May 10 2021 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 3,143 | 0 | 106,944 | 103.8 K to 106.9 K (+3.03 %) |
| Jun 05 2020 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 890 | 0 | 7,885 | 7 K to 7.9 K (+12.72 %) |
| May 15 2020 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 22.16 | 1,000 | 22,159 | 103,801 | 102.8 K to 103.8 K (+0.97 %) |
| May 08 2020 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 5,058 | 0 | 102,801 | 97.7 K to 102.8 K (+5.17 %) |
| May 08 2020 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 5,058 | 0 | 97,743 | 92.7 K to 97.7 K (+5.46 %) |
| May 08 2020 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 23.72 | 1,000 | 23,718 | 92,685 | 91.7 K to 92.7 K (+1.09 %) |
| Dec 03 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 292.35 | 1,055 | 308,429 | 6,995 | 8.1 K to 7 K (-13.11 %) |
| Jun 20 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 1,155 | 0 | 8,050 | 6.9 K to 8.1 K (+16.75 %) |
| May 09 2019 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 2,832 | 0 | 91,685 | 88.9 K to 91.7 K (+3.19 %) |
| May 09 2019 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 3,726 | 0 | 88,853 | 85.1 K to 88.9 K (+4.38 %) |
| Feb 15 2019 | IDPH | BIOGEN INC. | Posner Brian S | Director | Gift | G | 0.00 | 315 | 0 | 6,895 | 7.2 K to 6.9 K (-4.37 %) |
| Nov 29 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 28.24 | 500 | 14,119 | 85,127 | 84.6 K to 85.1 K (+0.59 %) |
| Nov 29 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 21.86 | 500 | 10,932 | 3,000 | 2.5 K to 3 K (+20.00 %) |
| Nov 06 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 22.45 | 2,500 | 56,124 | 2,500 | 0 to 2.5 K |
| Jun 14 2018 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 880 | 0 | 7,210 | 6.3 K to 7.2 K (+13.90 %) |
| May 10 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,196 | 0 | 28,209 | 27 K to 28.2 K (+4.43 %) |
| May 10 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,574 | 0 | 27,013 | 25.4 K to 27 K (+6.19 %) |
| May 04 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 77.38 | 1,000 | 77,380 | 25,439 | 24.4 K to 25.4 K (+4.09 %) |
| May 04 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 79.25 | 2,000 | 158,496 | 24,439 | 22.4 K to 24.4 K (+8.91 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 44.51 | 2,980 | 132,640 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 0.00 | 6,364 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Sell | D | 0.00 | 6,693 | 0 | 0 | 6.7 K to 0 (-100.00 %) |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 0.00 | 6,364 | 0 | 6,364 | |
| Jan 02 2018 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Sell | D | 25.00 | 2,146 | 53,650 | 0 | 2.1 K to 0 (-100.00 %) |
| Sep 26 2017 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Sell | D | 25.00 | 695 | 17,375 | 2,146 | 2.8 K to 2.1 K (-24.46 %) |
| Sep 19 2017 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Sell | D | 25.00 | 4,659 | 116,475 | 2,841 | 7.5 K to 2.8 K (-62.12 %) |
| Aug 10 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 59.19 | 1,000 | 59,190 | 6,693 | 5.7 K to 6.7 K (+17.57 %) |
| Jun 12 2017 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 256.31 | 1,084 | 277,840 | 6,330 | 7.4 K to 6.3 K (-14.62 %) |
| Jun 09 2017 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 1,055 | 0 | 7,414 | 6.4 K to 7.4 K (+16.59 %) |
| May 24 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 53.79 | 700 | 37,656 | 5,693 | 5 K to 5.7 K (+14.02 %) |
| May 24 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 53.90 | 1,300 | 70,068 | 4,993 | 3.7 K to 5 K (+35.20 %) |
| May 05 2017 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 771 | 0 | 22,439 | 21.7 K to 22.4 K (+3.56 %) |
| May 05 2017 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,286 | 0 | 21,668 | 20.4 K to 21.7 K (+6.31 %) |
| Apr 17 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Grant | A | 56.83 | 1,056 | 60,012 | 3,693 | 2.6 K to 3.7 K (+40.05 %) |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 44.51 | 2,974 | 132,373 | 2,974 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 44.51 | 2,974 | 132,373 | 2,974 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 | |
| Nov 21 2016 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Buy | P | 21.88 | 6,000 | 131,271 | 6,000 | 0 to 6 K |
| Jun 09 2016 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 1,060 | 0 | 6,335 | 5.3 K to 6.3 K (+20.09 %) |
| May 09 2016 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,066 | 0 | 20,382 | 19.3 K to 20.4 K (+5.52 %) |
| May 09 2016 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,777 | 0 | 19,316 | 17.5 K to 19.3 K (+10.13 %) |
| Jun 23 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 415.00 | 470 | 195,050 | 5,275 | 5.7 K to 5.3 K (-8.18 %) |
| Jun 16 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Sell | S | 386.64 | 400 | 154,656 | 5,745 | 6.1 K to 5.7 K (-6.51 %) |
| Jun 11 2015 | IDPH | BIOGEN INC. | Posner Brian S | Director | Grant | A | 0.00 | 695 | 0 | 6,145 | 5.5 K to 6.1 K (+12.75 %) |
| May 11 2015 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,201 | 0 | 17,539 | 16.3 K to 17.5 K (+7.35 %) |
| May 11 2015 | ACGL | ARCH CAPITAL GROUP ... | Posner Brian S | Director | Grant | A | 0.00 | 1,601 | 0 | 16,338 | 14.7 K to 16.3 K (+10.86 %) |
| Oct 11 2006 | SCD | LMP CAPITAL & ... | Posner Brian S | Officer of the Advi ... | Buy | P | 17.95 | 5,000 | 89,750 | 5,000 | 0 to 5 K |
Page: 1